The impact of anti-inflammatory cytokines on the pancreatic β-cell

M A Russell1, N G Morgan1

  • 1Institute of Biomedical and Clinical Science; University of Exeter Medical School ; Exeter , Devon , UK.

Islets
|October 18, 2014
PubMed

Insights

Anti-inflammatory cytokines like IL-4, IL-10, and IL-13 show promise in protecting pancreatic beta cells from damage in type 1 diabetes. Targeting these pathways could offer new therapeutic strategies for the disease.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Pro-inflammatory cytokines are known to cause beta-cell death in type 1 diabetes.
  • The protective roles of anti-inflammatory cytokines in beta-cells are less understood.
  • Reduced levels of certain anti-inflammatory cytokines are observed in type 1 diabetes.

Purpose of the Study:

  • To review the evidence for anti-inflammatory cytokines as beta-cell cytoprotective agents.
  • To explore the therapeutic potential of targeting anti-inflammatory pathways in type 1 diabetes.
  • To discuss the mechanisms, receptors, and signaling pathways involved.

Main Methods:

  • Literature review of studies on interleukin-4 (IL-4), interleukin-10 (IL-10), and interleukin-13 (IL-13) in beta-cells.
  • Analysis of research on cytokine receptor components and downstream signaling.
  • Examination of evidence linking cytokine levels to type 1 diabetes.

Main Results:

  • Interleukin-4 (IL-4), IL-10, and IL-13 demonstrate direct protective effects on beta-cell function and viability.
  • These anti-inflammatory cytokines may be reduced in type 1 diabetes patients.
  • Specific receptor interactions and signaling cascades mediate these cytoprotective effects.

Conclusions:

  • Anti-inflammatory cytokines IL-4, IL-10, and IL-13 are important cytoprotective agents for pancreatic beta-cells.
  • Therapeutic strategies targeting these anti-inflammatory pathways may be beneficial for type 1 diabetes.
  • Further research into the mechanisms of these cytokines is warranted for treatment development.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
8
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.7K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.2K
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
25
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
18
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
891